Risk for Lynch Syndrome Related Cancers in MSH6 Mutations

People with a mutation in the MSH6 gene, part of the Lynch syndrome, have a greatly increased risk of colorectal, endometrial, and other related cancers.  The cancers can occur in old age, with an increasing risk from age 70 to 80.

About 4 in every 1000 colorectal cancers are due to an inherited mutation in the MSH6 gene.  It accounts for about 10 to 20 percent of Lynch syndrome mutations.

By the time they are 80 years old, men have eight times the risk of getting colorectal cancer and women have 26 times the risk of endometrial cancer — cancer that begins in the lining of the uterus.

A research team identified 113 families with inherited MSH6 mutations in five countries, including 3,104 relatives.  They estimated the risk that they would have been diagnosed with a Lynch-related cancer by the time they were 70 and by the age of 80.  They also compared the risk of a cancer diagnosis in Lynch carriers to the general population.

For any Lynch-related cancer

Compared to other people without the Lynch-related MSH6 gene:

Lynch syndrome, also known as hereditary nonpolyposis colon cancer (HNPCC), is an increased cancer risk, inherited directly from parent to child.  Changes in the genes that repair damaged DNA increase the chances that cells can grow out of control and develop into cancer.

SOURCEBaglietto et al., Journal of the National Cancer Institute, Advance Access, December 22, 2009.

Bookmark and Share

This news article was originally posted on December 23rd, 2009 and was accurate at the time of publication. Since then, information may have changed or links may now be outdated. Please call our Answer Line 1-877-427-2111 for the latest information, or talk to your doctor before making any medical decisions.

Posted by Kate Murphy on December 23rd, 2009
Tags: inherited cancer, Lynch syndrome, MSH6

Leave a Comment Comments RSS

Your comments are welcome. However, specific medical advice will not be provided, and we urge you to consult with a qualified physician for diagnosis and for answers to your personal questions. C3 is not responsible for the medical accuracy of any comments left by persons other than C3 staff members. C3 staff members monitor comments and may respond publicly where appropriate.

Please note that we automatically publish the name that you enter next to your post. Also note that our pages are automatically indexed by Google and other search engines, and your name may therefore appear in search results on those sites. So if you wish to remain anonymous please use a different name or enter 'Anon' as the name.

We regret that we are unable to privately answer questions left as comments. So please do not include your phone number, email or mailing address in the body of your comment. For the best personal and direct response to your colorectal cancer treatment questions, please call our Answer Line at 1-877-4CRC-111 (1-877-427-2111).

Search C3

Register to receive our free e-newsletter

Get monthly updates on colorectal cancer treatment options, research news and advocacy opportunities. We promise to not bombard you with email - just enough to keep you informed on how to fight colorectal cancer.

First Name

Last Name

Email

Donate

Support C3 and the Lisa Fund for Research

Donate to C3

Donate to The Lisa Fund

Learn more about the Lisa Fund

Sign Our Petition

Guarantee access to colorectal cancer screening for all Americans who need it.

Get Involved

Subscribe to the C3 website

Get C3 news & updates

Get the latest articles in your email inbox or news reader as soon as they are published.

Subscribe